Perrigo Company plc (NYSE:PRGO) Shares Bought by Patriot Financial Group Insurance Agency LLC

Patriot Financial Group Insurance Agency LLC grew its holdings in shares of Perrigo Company plc (NYSE:PRGOFree Report) by 4.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 9,627 shares of the company’s stock after acquiring an additional 380 shares during the quarter. Patriot Financial Group Insurance Agency LLC’s holdings in Perrigo were worth $310,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Raymond James & Associates lifted its holdings in shares of Perrigo by 23.6% in the first quarter. Raymond James & Associates now owns 53,302 shares of the company’s stock valued at $2,048,000 after buying an additional 10,189 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Perrigo by 222.6% in the first quarter. PNC Financial Services Group Inc. now owns 8,039 shares of the company’s stock valued at $308,000 after buying an additional 5,547 shares during the period. Natixis Advisors L.P. lifted its holdings in shares of Perrigo by 135.4% in the first quarter. Natixis Advisors L.P. now owns 24,726 shares of the company’s stock valued at $950,000 after buying an additional 14,222 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Perrigo by 10.5% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 49,027 shares of the company’s stock valued at $1,884,000 after purchasing an additional 4,675 shares during the period. Finally, BlackRock Inc. boosted its position in shares of Perrigo by 4.8% in the 1st quarter. BlackRock Inc. now owns 12,112,154 shares of the company’s stock valued at $465,469,000 after purchasing an additional 554,915 shares during the period. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Stock Up 2.3 %

Shares of Perrigo stock opened at $32.19 on Monday. The stock has a 50-day moving average price of $31.09 and a 200 day moving average price of $30.91. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.79 and a quick ratio of 1.07. Perrigo Company plc has a 1 year low of $25.77 and a 1 year high of $40.28.

Perrigo (NYSE:PRGOGet Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.03. Perrigo had a positive return on equity of 7.34% and a negative net margin of 0.27%. The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the prior year, the business earned $0.75 EPS. The business’s revenue for the quarter was up .1% on a year-over-year basis. On average, research analysts expect that Perrigo Company plc will post 2.55 EPS for the current year.

Perrigo Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a dividend of $0.276 per share. The ex-dividend date of this dividend was Thursday, March 7th. This is an increase from Perrigo’s previous quarterly dividend of $0.27. This represents a $1.10 dividend on an annualized basis and a dividend yield of 3.43%. Perrigo’s dividend payout ratio (DPR) is -1,100.00%.

Insider Transactions at Perrigo

In other news, EVP Robert Willis purchased 6,000 shares of the business’s stock in a transaction dated Thursday, February 29th. The stock was bought at an average cost of $25.87 per share, with a total value of $155,220.00. Following the purchase, the executive vice president now directly owns 25,105 shares of the company’s stock, valued at $649,466.35. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Robert Willis purchased 6,000 shares of the business’s stock in a transaction dated Thursday, February 29th. The stock was bought at an average cost of $25.87 per share, with a total value of $155,220.00. Following the purchase, the executive vice president now directly owns 25,105 shares of the company’s stock, valued at $649,466.35. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Patrick Lockwood-Taylor acquired 9,500 shares of the business’s stock in a transaction that occurred on Thursday, February 29th. The stock was bought at an average cost of $26.54 per share, for a total transaction of $252,130.00. Following the completion of the purchase, the chief executive officer now directly owns 20,500 shares in the company, valued at approximately $544,070. The disclosure for this purchase can be found here. Insiders bought 17,990 shares of company stock valued at $475,227 in the last three months. Corporate insiders own 0.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on PRGO. JPMorgan Chase & Co. decreased their price target on Perrigo from $48.00 to $41.00 and set an “overweight” rating for the company in a research report on Wednesday, February 28th. StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a research note on Thursday, March 7th.

View Our Latest Stock Analysis on Perrigo

Perrigo Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Read More

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGOFree Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.